<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref39">
 <mixed-citation publication-type="journal" id="cit39">
  <name>
   <surname>Dibo</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Battocchio</surname>
   <given-names>E. C.</given-names>
  </name>; 
  <name>
   <surname>dos Santos Souza</surname>
   <given-names>L. M.</given-names>
  </name>; 
  <name>
   <surname>da Silva</surname>
   <given-names>M. D. V.</given-names>
  </name>; 
  <name>
   <surname>Banin-Hirata</surname>
   <given-names>B. K.</given-names>
  </name>; 
  <name>
   <surname>Sapla</surname>
   <given-names>M. M. M.</given-names>
  </name>; 
  <name>
   <surname>Marinello</surname>
   <given-names>P.</given-names>
  </name>; 
  <name>
   <surname>Rocha</surname>
   <given-names>S. P.D.</given-names>
  </name>; 
  <name>
   <surname>Faccin-Galhardi</surname>
   <given-names>L. C.</given-names>
  </name>
  <article-title>Antibody therapy for the control of viral diseases: an update</article-title>. 
  <source>Curr. Pharm. Biotechnol.</source>
  <year>2019</year>, 
  <volume>20</volume>, 
  <fpage>1108</fpage>â€“
  <lpage>1121</lpage>. 
  <pub-id pub-id-type="doi">10.2174/1389201020666190809112704</pub-id>.
  <pub-id pub-id-type="pmid">31400263</pub-id>
 </mixed-citation>
</ref>
